Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Nitrite (NO2−) is an intrinsic signaling molecule that is reduced to NO during ischemia and limits apoptosis and cytotoxicity at reperfusion in the mammalian heart, liver, and brain. Although the mechanism of nitrite-mediated cytoprotection is unknown, NO is a mediator of the ischemic preconditioning cell-survival program. Analogous to the temporally distinct acute and delayed ischemic preconditioning cytoprotective phenotypes, we report that both acute and delayed (24 h before ischemia) exposure to physiological concentrations of nitrite, given both systemically or orally, potently limits cardiac and hepatic reperfusion injury. This cytoprotection is associated with increases in mitochondrial oxidative phosphorylation. Remarkably, isolated mitochondria subjected to 30 min of anoxia followed by reoxygenation were directly protected by nitrite administered both in vitro during anoxia or in vivo 24 h before mitochondrial isolation. Mechanistically, nitrite dose-dependently modifies and inhibits complex I by posttranslational S-nitrosation; this dampens electron transfer and effectively reduces reperfusion reactive oxygen species generation and ameliorates oxidative inactivation of complexes II–IV and aconitase, thus preventing mitochondrial permeability transition pore opening and cytochrome c release. These data suggest that nitrite dynamically modulates mitochondrial resilience to reperfusion injury and may represent an effector of the cell-survival program of ischemic preconditioning and the Mediterranean diet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







![Figure 8. Hepatic and myocardial I/R injury are attenuated in mice after oral nitrite therapy. (A) The effects of oral nitrite preconditioning (PC) on the severity of hepatic I/R injury (measured as aspartate aminotransferase [AST] and ALT) in mice. Mice received nitrite via oral gavage at 24 h before 45 min of hepatic ischemia and 5 h of reperfusion. Numbers for each group are shown inside the bars. (B) Bar graph of oral nitrite preconditioning and myocardial I/R injury in mice. Mice received oral nitrite at 24 h before 30 min of ischemia and 24 h of reperfusion. The myocardial area-at-risk (AAR) per total left ventricle (LV) was not significantly different between study groups (NS). The myocardial infarct size (Inf) per area-at-risk was significantly (P < 0.0001) reduced in the oral nitrite preconditioning group when compared with the oral vehicle group. Eight animals were investigated in each group.](https://figures.cochat.ai/paper-figures/87568cfe94304576a2939f5b2387fbfb/nitrite-augments-tolerance-to-ischemia-reperfusion-injury-via-the-modulation-of-figure-8.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“previous work has shown that complex I is inhibited by various nitric oxide donors in vitro and that this inhibition is associated with S-nitrosation2,10,11,21–24.”
From Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I (2013) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while nitrate supplementation prevents or limits ischemia-reperfusion injury and endothelial dysfunction in both animal[98,120–124] and human[97,125] models of ischemia-reperfusion.”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Shiva et al., recently showed that the nitrite stored in the heart and liver via systemic and oral routes augmented the tolerance to ischemia/reperfusion injury in the mouse heart and liver [33].”
From NO-Rich Diet for Lifestyle-Related Diseases (2015) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The efficacy of low concentrations of nitrite in mediating cytoprotection has been demonstrated in a variety of tissues in animal models including heart [8, 9, 55, 118–122] liver [9, 120, 123], brain [124–126], kidney [127, 128], hindlimb [129], and human forearm [23].”
From Mechanisms of nitrite bioactivation (2014) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Shiva et al elegantly demonstrated that nitrite therapy significantly blunted mitochondrial uncoupling during in vivo ischemia reperfusion through nitrite mediated, NO dependent, inhibition of mitochondrial complex I activity [40].”
From Inorganic nitrite therapy: historical perspective and future directions (2011) · cites this paper as [40]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C. D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu, X., et al. (2003) · Nature Medicine · doi:10.1038/nm954 · Cited by 1,807
Self-citationMyocardial reperfusion: a double-edged sword?
Braunwald, E., & Kloner, R. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112160 · Cited by 1,367 · cited 1×
“…Ischemia/reperfusion (I/R) injury is characterized by several cellular events, including the release of tissue enzymes, oxidative modifi cation of essential proteins and lipids, and a dysregulated infl ammatory response, which ultimately leads to tissue necrosis and apoptosis ( 1, 2 ).”
BackgroundMitochondrial biogenesis in mammals: the role of endogenous nitric oxide
Nisoli, E., Clementi, E., Paolucci, C., Cozzi, V., Tonello, C., Sciorati, C., Bracale, R., Valerio, A., Francolini, M., Moncada, S., et al. (2003) · Science · doi:10.1126/science.1079368 · Cited by 1,243 · cited 2×
“NO is a well-characterized regulator of mitochondrial function, with nanomolar concentrations reversibly inhibiting cytochrome c oxidase ( 24, 25 ), regulating ROS formation ( 26, 27 ), initiating biogenesis ( 28, 29 ), and limiting apoptotic cytochrome c release ( 30, 31 ).”
BackgroundCleeter, M. W. J., Cooper, J. M., Darley-Usmar, V. M., Moncada, S., & Schapira, A. H. V. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00424-2 · Cited by 1,241
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062 · cited 1×
“Transient nonlethal ischemia, termed the ischemic preconditioning “ trigger, ” evokes cellular resilience to I/R ( 32 ).”
BackgroundBrown, G. C., & Cooper, C. E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01290-3 · Cited by 1,055 · cited 1×
“NO is a well-characterized regulator of mitochondrial function, with nanomolar concentrations reversibly inhibiting cytochrome c oxidase ( 24, 25 ), regulating ROS formation ( 26, 27 ), initiating biogenesis ( 28, 29 ), and limiting apoptotic cytochrome c release ( 30, 31 ).”
BackgroundEnzyme-independent formation of nitric oxide in biological tissues
Zweier, J. L., Wang, P., Samouilov, A., & Kuppusamy, P. (1995) · Nature Medicine · doi:10.1038/nm0895-804 · Cited by 788 · cited 1×
“…NO along a physiological pH and oxygen gradient by several mechanisms, including enzymatic reduction by hemoglobin, myoglobin ( 12–14 ), components of the mitochondrial respiratory chain ( 15 ), and xanthine oxidoreductase ( 16 ), as well as nonenzymatically by acidic disproportionation ( 17, 18 ).”
BackgroundPoderoso, J. J., Carreras, M. C., Lisdero, C., Riobó, N., Schöpfer, F., & Boveris, A. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0146 · Cited by 726
Mitochondrial Dysfunction in Cardiac Disease: Ischemia–Reperfusion, Aging, and Heart Failure
Lesnefsky, E. J., Moghaddas, S., Tandler, B., Kerner, J., & Hoppel, C. L. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1378 · Cited by 709 · cited 2×
“…observed a nitrite-dependent protection of the complex II respiratory rate after anoxia/reoxygenation, it is important to also consider the eff ects of nitrite on complex I – dependent respiration, because complex I is known to be a primary site of both injury and ROS production after I/R ( 37 ).”
BackgroundKUSHNAREVA, Y., MURPHY, A. N., & ANDREYEV, A. (2002) · Biochemical Journal · doi:10.1042/bj20021121 · Cited by 677 · cited 1×
“In brief, in an aerobic environment with adequate oxidative phosphorylation, substrate, and reducing equivalents, the direct inhibition of complex I with either rotenone ( 54 ) or by preformed SNOs ( 40 ) results in complex I – derived ROS production.”
Background
Research works printed but not linked: 5
- 1996, Cardiovasc. Res., 32, 743, 10.1016/S0008-6363(96)00073-9 · doi:10.1016/s0008-6363(96)00073-9 · Paper page
- 1990, Am. J. Physiol., 259, H1759
- 1983, Am. J. Physiol., 244, H743
- 2005, Blood., 106, 734
- 2003, Free Radic. Res., 37, 1
Cited by
Items 101–200 of 554
Nitrates and Nitrites in the Treatment of Ischemic Cardiac Disease
Nossaman, V. E., Nossaman, B. D., & Kadowitz, P. J. (2010) · Cardiology in Review · doi:10.1097/crd.0b013e3181c8e14a · Cited by 117
Inorganic nitrite therapy: historical perspective and future directions
Kevil, C. G., Kolluru, G. K., Pattillo, C. B., & Giordano, T. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.042 · Cited by 113
“Moreover, nitrite administration can precondition liver and heart tissue against subsequent ischemic injury by protecting against mitochondrial dysfunction, enhancing tissue reperfusion respiration and energetics, and limiting ROSmediated cellular dysfunction [40].”
BackgroundResultS-nitrosylation: A radical way to protect the heart
Murphy, E., Kohr, M., Sun, J., Nguyen, T., & Steenbergen, C. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.08.021 · Cited by 113
“Recent data has suggested a role for SNO in cardioprotection, and a number of studies have shown an association between an increase in SNO and cardioprotection [1,4,7,14,15,23,24,46–49].”
BackgroundMerkel cell carcinoma: combined surgery and radiation therapy.
Cotlar, A. M., Gates, J., & Gibbs, F. A. (1986) · PubMed · Cited by 117
Dietary nitrite improves insulin signaling through GLUT4 translocation
Jiang, H., Torregrossa, A. C., Potts, A., Pierini, D., Aranke, M., Garg, H. K., & Bryan, N. S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.809 · Cited by 105
Randomized Phase 2 Trial of Intracoronary Nitrite During Acute Myocardial Infarction
Jones, D. A., Pellaton, C., Velmurugan, S., Rathod, K. S., Andiapen, M., Antoniou, S., van Eijl, S., Webb, A. J., Westwood, M. A., Parmar, M. K., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.305082 · Cited by 105
The breathing heart — Mitochondrial respiratory chain dysfunction in cardiac disease
Schwarz, K., Siddiqi, N., Singh, S., Neil, C., Dawson, D. K., & Frenneaux, M. P. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.014 · Cited by 108
Moving Forwards by Blocking Back-Flow
Pell, V. R., Chouchani, E. T., Murphy, M. P., Brookes, P. S., & Krieg, T. (2016) · Circulation Research · doi:10.1161/circresaha.115.306569 · Cited by 111
Self-citationCancer cell metabolism and the modulating effects of nitric oxide
Chang, C.-F., Diers, A. R., & Hogg, N. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.012 · Cited by 102
Zand, J., Lanza, F., Garg, H. K., & Bryan, N. S. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.03.008 · Cited by 101
“Dietary supplementation of nitrite and nitrate in mice has shown to reverse endothelial dysfunction, suppress microvascular inflammation, reduce levels of C-reactive protein in mice subjected to a high-cholesterol diet [23], and protect from ischemia reperfusion injury [24,42,43].”
BackgroundAlef, M. J., Vallabhaneni, R., Carchman, E., Morris, S. M., Shiva, S., Wang, Y., Kelley, E. E., Tarpey, M. M., Gladwin, M. T., Tzeng, E., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44079 · Cited by 101
Self-citationBrief Periods of Nitric Oxide Inhalation Protect against Myocardial Ischemia–Reperfusion Injury
Nagasaka, Y., Fernandez, B. O., Garcia-Saura, M. F., Petersen, B., Ichinose, F., Bloch, K. D., Feelisch, M., & Zapol, W. M. (2008) · Anesthesiology · doi:10.1097/aln.0b013e318186316e · Cited by 102
“Nitrite protected the heart when injected into the left ventricle at 5 min before the reperfusion(31) and produced cardioprotection by attenuating mitochondrial respiration via inhibiting complex I in vitro.(32) Moreover, a recent study indicates that S-nitrosocysteine may protect the heart through nitric oxide–indepe…”
BackgroundPignataro, G., Scorziello, A., Di Renzo, G., & Annunziato, L. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06769.x · Cited by 100
Morris, G., Berk, M., Klein, H. C., Walder, K. R., Gałecki, P., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9975-2 · Cited by 103
Cysteine-mediated redox signalling in the mitochondria
Bak, D. W., & Weerapana, E. (2014) · Molecular BioSystems · doi:10.1039/c4mb00571f · Cited by 99
Zuckerbraun, B. S., George, P., & Gladwin, M. T. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq370 · Cited by 98
Self-citationCarlstrom, M., & Montenegro, M. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12818 · Cited by 96
Raat, N. J. H., Noguchi, A. C., Liu, V. B., Raghavachari, N., Liu, D., Xu, X., Shiva, S., Munson, P. J., & Gladwin, M. T. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.015 · Cited by 97
“[9] showed that nitrite administration by oral gavage (20 ug) in mice was enough to reduce cardiac I.”
BackgroundMethodPride, C. K., Mo, L., Quesnelle, K., Dagda, R. K., Murillo, D., Geary, L., Corey, C., Portella, R., Zharikov, S., St Croix, C., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvt224 · Cited by 97
“Cardiovascular Research (2014) 101, 57–68 doi:10.1093/cvr/cvt224 D ow nloaded from https://academ ic.oup.com /cardiovascres/article-abstract/101/1/57/273151 by guest on 08 M arch 2019 sub-lethal ischaemia,16,17 volatile anaesthetics,18 and adenosine.19 For example, the inhibition of ATP production and the incremental…”
InfluentialSelf-citationZhu, S.-G., Kukreja, R. C., Das, A., Chen, Q., Lesnefsky, E. J., & Xi, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.024 · Cited by 96
Ischemic Postconditioning: From Receptor to End-Effector
Cohen, M. V., & Downey, J. M. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3318 · Cited by 106
The nitrate‐nitrite‐nitric oxide pathway: Its role in human exercise physiology
Bailey, S. J., Vanhatalo, A., Winyard, P. G., & Jones, A. M. (2012) · European Journal of Sport Science · doi:10.1080/17461391.2011.635705 · Cited by 95
“This NO2 reduction is catalysed by deoxyhaemoglobin (Cosby et al., 2003), deoxymyoglobin (Shiva et al., 2007a), NOS (Vanin, Bevers, Slama-Schwok, & van Faassen, 2007), xanthine oxidase (Zhang et al., 1998), alde- hyde oxidase (Li, Cui, Kundu, Alzawahra, & Zweier, 2008), cytochrome P-450 (Kozlov,…”
MethodNO-Rich Diet for Lifestyle-Related Diseases
Kobayashi, J., Ohtake, K., & Uchida, H. (2015) · Nutrients · doi:10.3390/nu7064911 · Cited by 94
“Various enzyme/protein-dependent reductions to NO have been proposed under physiological and pathological conditions, which include deoxyhemoglobin [31], deoxymyoglobin in the skeletal, vascular [32], and cardiac muscles [33], xanthine oxidase in endothelial cells, aldehyde oxidase, aldehyde dehydrogenase 2 [34], cyto…”
Background“Oxygen Sensing” by Na,K-ATPase: These Miraculous Thiols
Bogdanova, A. Y., Petrushanko, I. Y., Hernansanz‐Agustín, P., & Martínez-Ruiz, A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00314 · Cited by 111
“Nitrite causes inhibition of complex I by S-nitrosylation (reviewed inMartinez-Ruiz et al., 2011) and decreases free radical generation in tissues exposed to ischemia-reperfusion (Shiva et al., 2007).”
BackgroundDietary nitrate reduces resting metabolic rate: A randomized, crossover study in humans
Larsen, F. J., Schiffer, T. A., Ekblom, B., Mattsson, M. P., Checa, A., Wheelock, C. E., Nyström, T., Lundberg, J. O., & Weitzberg, E. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.079491 · Cited by 92
“In recent years, a number of studies have shown a biological activity of this nitrate-nitrite-NO pathway including protection against ischemia-reperfusion injury (12), a reduction in blood pressure (12, 13), and the modulation of mitochondrial function (14, 15).”
BackgroundInorganic nitrate and the cardiovascular system
Kapil, V, Webb, A. J., & Ahluwalia, A. (2010) · Heart · doi:10.1136/hrt.2009.180372 · Cited by 91
Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function
Shiva, S., & Gladwin, M. T. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0009-3 · Cited by 91
“Nitrite has now been shown by a number of investigators to be cytoprotective in animal models of I/R in the heart [8, 21, 52 , 57], liver [21, 52, 53], brain [33] and kidney [55].”
BackgroundMethodInfluentialSelf-citationJežek, P., Plecitá‐Hlavatá, L., Smolková, K., & Rossignol, R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.008 · Cited by 109
Cardioprotection Through S -Nitros(yl)ation of Macrophage Migration Inhibitory Factor
Luedike, P., Hendgen-Cotta, U. B., Sobierajski, J., Totzeck, M., Reeh, M., Dewor, M., Lue, H., Krisp, C., Wolters, D., Kelm, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.069104 · Cited by 90
Chasing Cysteine Oxidative Modifications: Proteomic Tools for Characterizing Cysteine Redox Status
Murray, C. I., & Van Eyk, J. E. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961425 · Cited by 88
Mitochondria as metabolizers and targets of nitrite
Shiva, S. (2010) · Nitric Oxide · doi:10.1016/j.niox.2009.09.002 · Cited by 87
“While the physiological role of the mitochondrion as a nitrite reductase is still controversial, accumulating data now suggests that the mitochondrion may be a central physiological target for nitrite during hypoxia and ischemia [6,13,15,54,60,62].”
InfluentialSelf-citationRegulation of mitochondrial function and energetics by reactive nitrogen oxides
Larsen, F. J., Schiffer, T. A., Weitzberg, E., & Lundberg, J. O. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.580 · Cited by 87
Myoglobin and mitochondria: A relationship bound by oxygen and nitric oxide
Kamga, C., Krishnamurthy, S., & Shiva, S. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.005 · Cited by 105
“Indeed, nitrite has been shown to be protective in a number of models of ischemia/ reperfusion [92; 93; 94; 95; 96; 97].”
BackgroundSelf-citationMechanisms underlying blood pressure reduction by dietary inorganic nitrate
Carlström, M., Lundberg, J. O., & Weitzberg, E. (2018) · Acta Physiologica · doi:10.1111/apha.13080 · Cited by 86
“This process, which is associated with reduced generation of ROS, seems to be important in the cytoprotective effects of NO and other nitrogen intermediates generated from nitrate and nitrite, such as the protection described during ischaemia-reperfusion injury.(234) Another way by which nitrate-derived NO or other re…”
BackgroundNeuroprotective effects and mechanisms of ischemic/hypoxic preconditioning on neurological diseases
Liu, J., Gu, Y., Guo, M., & Ji, X. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13642 · Cited by 86
Myocardial protection by nitrite
Calvert, J. W., & Lefer, D. J. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp079 · Cited by 82
“Indeed, Shiva et al.(63) have reported that the reduction of nitrite to NO results in the inhibition of complex I of the mitochondrial transport chain by post-translational S-nitrosation.”
BackgroundResultHypoxia Tolerance, Nitric Oxide, and Nitrite: Lessons From Extreme Animals
Fago, A., & Jensen, F. B. (2015) · Physiology · doi:10.1152/physiol.00051.2014 · Cited by 87
Cauwels, A., Buys, E. S., Thoonen, R., Geary, L., Delanghe, J., Shiva, S., & Brouckaert, P. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091236 · Cited by 80
Self-citationEndoplasmic reticulum stress-mediated mitochondrial dysfunction in aged hearts
Chen, Q., Samidurai, A., Thompson, J., Hu, Y., Das, A., Willard, B. B., & Lesnefsky, E. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165899 · Cited by 81
Effects of nitrite on modulating ROS generation following ischemia and reperfusion
Raat, N. J. H., Shiva, S., & Gladwin, M. T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.002 · Cited by 79
Self-citationBench to bedside review: therapeutic modulation of nitric oxide in sepsis—an update
Lambden, S. (2019) · Intensive Care Medicine Experimental · doi:10.1186/s40635-019-0274-x · Cited by 83
Castiglione, N., Rinaldo, S., Giardina, G., Stelitano, V., & Cutruzzolà, F. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4196 · Cited by 79
“…the finding that nitrite may act as endocrine reservoir of NO has prompted many studies demonstrating the capability of nitrite to mediate potent cytoprotection ( via NO) in a number of organs and animal models of I/R injury [see (102)], also by modulating mitochondrial electron transfer (313).”
Strategic localization of heart mitochondrial NOS: a review of the evidence
Zaobornyj, T., & Ghafourifar, P. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00674.2011 · Cited by 86
Morris, G., Puri, B. K., Walder, K. R., Berk, M., Stubbs, B., Maes, M. H. J., & Carvalho, A. F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1028-6 · Cited by 81
Phillips, D. J., Covián, R., Aponte, A. M., Glancy, B. C., Taylor, J. F., Chess, D. J., & Balaban, R. S. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00596.2011 · Cited by 77
“Additionally, several PTMs have been correlated with alteration in Complex I (17, 64, 79), Complex IV (1, 12, 52), and Complex V (76, 84) activities.”
BackgroundPlasma nitrite response and arterial reactivity differentiate vascular health and performance
Allen, J. D., Miller, E. M., Schwark, E., Robbins, J. L., Duscha, B. D., & Annex, B. H. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.01.002 · Cited by 76
“Recent studies suggest nitrite protects against ischemia–reperfusion injury [39,40] and may regulate gene expression [41].”
BackgroundRedox signalling and cardioprotection: translatability and mechanism
Pagliaro, P., & Penna, C. R. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12975 · Cited by 80
“The inhibition of F0-F1-ATPase preserves ATP levels and reduces the mitochondrial potential, thereby reducing the driving force for Ca2+ uptake into the mitochondria, thus increasing tolerance to I/R (Shiva et al., 2007).”
BackgroundInfluentialLiesa, M., Luptak, I., Qin, F., Hyde, B. B., Sahin, E., Siwik, D. A., Zhu, Z., Pimentel, D. R., Xu, X. J., Ruderman, N. B., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.003418 · Cited by 74
Kemmner, S., Lorenz, G., Wobst, J., Kessler, T., Wen, M., Günthner, R., Stock, K., Heemann, U., Burkhardt, K., Baumann, M., et al. (2017) · Nitric Oxide · doi:10.1016/j.niox.2017.01.011 · Cited by 74
Unmasking the Janus face of myoglobin in health and disease
Hendgen-Cotta, U. B., Flögel, U., Kelm, M., & Rassaf, T. (2010) · Journal of Experimental Biology · doi:10.1242/jeb.041178 · Cited by 73
“, 2004), and it has been reported that nitrite modulates the mitochondrial resilience to reperfusion injury by the reversible inhibition of complex I via S-nitrosation (Shiva et al., 2007b).”
BackgroundInfluentialKurochkin, I. O., Ivanina, A. V., Eilers, S., Downs, C. A., May, L. A., & Sokolova, I. M. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00324.2009 · Cited by 84
Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?
Kozlov, A. V., Bahrami, S., Calzia, E., Dungel, P., Gille, L., Kuznetsov, A. V., & Troppmair, J. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-41 · Cited by 82
“transition pore opening and cytochrome c release [168].”
BackgroundBice, J. S., Jones, B. R., Chamberlain, G. R., & Baxter, G. F. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0540-y · Cited by 77
“Modification of the electron transport chain by S-nitrosation has also been well documented as a means of cytopro-tection, ultimately inhibiting mitochondrial transition pore opening and reducing cyctochrome-c release [17, 58].”
Clinical translation of nitrite therapy for cardiovascular diseases
Calvert, J. W., & Lefer, D. J. (2010) · Nitric Oxide · doi:10.1016/j.niox.2009.11.001 · Cited by 72
“However, it has been universally shown that nitrite-mediated protection is independent of eNOS and heme oxygenase-1 enzyme activities [14] and completely dependent on NO generation [13,14,21].”
BackgroundSelf-citationAge-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47
Frazier, E. P., Isenberg, J. S., Shiva, S., Zhao, L., Schlesinger, P. H., Dimitry, J. M., Abu-Asab, M. S., Tsokos, M., Roberts, D. D., & Frazier, W. A. (2011) · Matrix Biology · doi:10.1016/j.matbio.2010.12.004 · Cited by 77
“Mitochondria isolated from skeletal leg muscles were assayed for activity of electron transport enzymes as described (Shiva et al., 2007).”
MethodSelf-citationIn vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycine
Nadtochiy, S. M., Burwell, L. S., Ingraham, C. A., Spencer, C. M., Friedman, A. E., Pinkert, C. A., & Brookes, P. S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.012 · Cited by 72
“nitrite [25], which is about to enter clinical trials for myocardial infarction), may afford novel therapeutics for IR injury in humans.”
BackgroundSelf-citationNitrate/Nitrite as Critical Mediators to Limit Oxidative Injury and Inflammation
Waltz, P., Escobar, D., Botero, A. M., & Zuckerbraun, B. S. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6256 · Cited by 70
Bueno, M., Wang, J., Mora, A. L., & Gladwin, M. T. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4833 · Cited by 68
A novel role for cytochrome c: Efficient catalysis of S-nitrosothiol formation
Basu, S., Keszler, A., Azarova, N. A., Nwanze, N., Perlegas, A., Shiva, S., Broniowska, K. A., Hogg, N., & Kim-Shapiro, D. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.049 · Cited by 69
“Complex I activity was also measured in the SMP fraction by monitoring the rotenone sensitive oxidation of NADH at 340 nm as previously described [25].”
MethodSelf-citationNitrite and nitrate: cardiovascular risk–benefit and metabolic effect
Tang, Y., Jiang, H., & Bryan, N. S. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328341942c · Cited by 69
Inorganic nitrite supplementation for healthy arterial aging
Sindler, A. L., DeVan, A. E., Fleenor, B. S., & Seals, D. R. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01100.2013 · Cited by 68
Nitrite Reductase Activity of Nonsymbiotic Hemoglobins from Arabidopsis thaliana
Tiso, M., Tejero, J., Kenney, C., Frizzell, S., & Gladwin, M. T. (2012) · Biochemistry · doi:10.1021/bi300570v · Cited by 69
“In mammalian cells, deoxy-hemeproteins related NO production was observed to inhibit mitochondrial respiration (at the complex I and complex IV level) and prevent electron leakage with subsequent formation of superoxide and peroxynitrite at the site of complex I and III (16, 46).”
BackgroundSelf-citationShining a light on tissue NO stores: Near infrared release of NO from nitrite and nitrosylated hemes
Shiva, S., & Gladwin, M. T. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.005 · Cited by 76
“This inhibition of complex I also decreases reactive oxygen species generation at reperfusion, which in turn prevents oxidative damage to other mitochondrial proteins and prevents cytochrome c release [26].”
BackgroundSelf-citationMyalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?
Morris, G., Maes, M. H. J., Berk, M., & Puri, B. K. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-0388-6 · Cited by 79
“…(Levy et al. 2005; Liu et al. 2011a; Singer 2008) (reviewed (Singer 2017)) and it is important to stress that this phenomenon is not limited to macrophages and monocytes but also takes place in hepatocytes and striated muscle cells (Carré and Singer 2008; McCall et al. 2011; Singer 2007, 2008).”
BackgroundMyoglobin functions in the heart
Hendgen-Cotta, U. B., Kelm, M., & Rassaf, T. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.005 · Cited by 75
Milsom, A. B., Patel, N. S. A., Mazzon, E., Tripatara, P., Storey, A., Mota-Filipe, H., Sepodes, B., Webb, A. J., Cuzzocrea, S., Hobbs, A. J., et al. (2010) · Nitric Oxide · doi:10.1016/j.niox.2009.10.010 · Cited by 67
Activation of mitochondrial calpain and increased cardiac injury: beyond AIF release
Thompson, J., Hu, Y., Lesnefsky, E. J., & Chen, Q. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00748.2015 · Cited by 67
“The mechanisms of complex I damage during IR involved posttranslational modification and complex I subunit damage (6, 24, 28, 43).”
BackgroundChen, Q., Thompson, J., Hu, Y., Dean, J., & Lesnefsky, E. J. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00190.2019 · Cited by 68
Moayeri, M., Crown, D., Dorward, D. W., Gardner, D., Ward, J. M., Li, Y., Cui, X., Eichacker, P. Q., & Leppla, S. H. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000456 · Cited by 66
“successful in certain ischemia/reperfusion injury models [43], it is possible that concentrations of NO adequate to protect against LT were not achieved.”
BackgroundContribution of Delayed Intracellular pH Recovery to Ischemic Postconditioning Protection
Inserte, J., Ruiz‐Meana, M., Rodríguez‐Sinovas, A., Barba, I., & García‐Dorado, D. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3312 · Cited by 64
Mo, L., Wang, Y., Geary, L., Corey, C., Alef, M. J., Beer-Stolz, D., Zuckerbraun, B. S., & Shiva, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.080 · Cited by 62
“While we demonstrate that NO2 mediates biogenesis in vivo, prior studies have reported a lack of NO2-mediated biogenesis in other animal models [31, 49].”
BackgroundMethodSelf-citationRassaf, T., Ferdinandy, P., & Schulz, R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12291 · Cited by 62
“This prevents mitochondrial permeability transition pore opening and cytochrome c release (Shiva et al., 2007).”
BackgroundZemke, A. C., Shiva, S., Burns, J. L., Moskowitz, S. M., Pilewski, J. M., Gladwin, M. T., & Bomberger, J. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.011 · Cited by 61
“In eukaryotes, mitochondrial complex I is a target for cysteine S-nitrosation, which confers protection from ischemia/perfusion injury (52, 53).”
BackgroundSelf-citationThe role of vascular myoglobin in nitrite-mediated blood vessel relaxation
Ormerod, J. O. M., Ashrafian, H., Maher, A. R., Arif, S., Steeples, V., Born, G. V. R., Egginton, S., Feelisch, M., Watkins, H., & Frenneaux, M. P. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq299 · Cited by 61
Lu, Z., Scott, I., Webster, B. R., & Sack, M. N. (2009) · Circulation Research · doi:10.1161/circresaha.109.204974 · Cited by 61
Self-citationIsenberg, J. S., Shiva, S., & Gladwin, M. (2009) · Nitric Oxide · doi:10.1016/j.niox.2009.05.005 · Cited by 60
“This cytoprotective effect of nitrite has been observed in animal models of ischemia-reperfusion of the heart, liver, and brain [25].”
BackgroundMethodSelf-citationPharmacology and therapeutic role of inorganic nitrite and nitrate in vasodilatation
Bailey, J., Feelisch, M., Horowitz, J. D., Frenneaux, M. P., & Madhani, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.009 · Cited by 65
“…bioactivity is cardioprotective by minimising cell death by apoptosis (Webb et al., 2004; Duranski et al., 2005; Dezfulian et al., 2007; Shiva et al., 2007a, 2007b; Tripatara et al., 2007), exerts anti-aggregatory effects (Srihirun et al., 2012; Corti et al., 2013; Park et al., 2013;…”
Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity
Nguyen, Q. L., Corey, C. G., White, P., Watson, A. M. M., Gladwin, M. T., Simon, M. A. M., & Shiva, S. (2017) · JCI Insight · doi:10.1172/jci.insight.91415 · Cited by 62
Self-citationVitturi, D. A., & Patel, R. P. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.037 · Cited by 59
“This is exemplified by the nitrite-induced S-nitrosation of complex I of the electron transport chain which decreases mitochondrial reactive species formation and subsequently confers protection against ischemia-reperfusion injury [104] [33, 86, 105, 106].”
BackgroundKhatri, J., Mills, C. E., Maskell, P., Odongerel, C., & Webb, A. J. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12913 · Cited by 59
Targeting the NO/superoxide ratio in adipose tissue: relevance to obesity and diabetes management
Jankovic, A., Korac, A., Buzadzic, B., Stancic, A., Otasevic, V., Ferdinandy, P., Daiber, A., & Korac, B. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13498 · Cited by 59
“, 2003) or ischaemia/reperfusion injury andmyocardial ischaemic conditioning (Shiva et al., 2007; also see Andreadou et al., 2015).”
BackgroundAshmore, T., Fernandez, B. O., Branco‐Price, C., West, J. A., Cowburn, A. S., Heather, L. C., Griffin, J. L., Johnson, R. S., Feelisch, M., & Murray, A. J. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.275263 · Cited by 58
“Meanwhile nitrite, a product of either NO oxidation or nitrate reduction, has been found to protect mitochondria during ischaemia/reperfusion, ameliorating the rise in ROS production and cytochrome c release, whilst preserving ATP synthesis (Shiva et al. 2007).”
BackgroundNitrite as a mediator of ischemic preconditioning and cytoprotection
Murillo, D., Kamga, C., Mo, L., & Shiva, S. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.01.003 · Cited by 57
“The administration of oral or intravenous nitrite 24 hours prior to the onset of hepatic or myocardial IR decreases circulating levels of alanine aminotransferase or diminishes infarct size respectively [53].”
BackgroundMethodInfluentialSelf-citationMethner, C., Chouchani, E. T., Buonincontri, G., Pell, V. R., Sawiak, S. J., Murphy, M. P., & Krieg, T. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.100 · Cited by 62
Keeping the heart in balance: the functional interactions of myoglobin with nitrogen oxides
Flögel, U., Fago, A., & Rassaf, T. (2010) · Journal of Experimental Biology · doi:10.1242/jeb.041681 · Cited by 60
“Since it has been shown that the reaction accelerates as tissue pH drops (Shiva et al., 2007a), Mb-dependent reduction of nitrite should further be enhanced under ischemia.”
BackgroundInfluentialSandvik, G. K., Nilsson, G., & Jensen, F. B. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00538.2011 · Cited by 64
“Like for the heart, nitrite has been found to protect brain (44), kidney (76), and liver (21, 64) tissue against ischemiareperfusion injury in mammals.”
BackgroundInfluentialMitochondria: The Missing Link Between Preconditioning and Neuroprotection
Correia, S. C., Santos, R. X., Perry, G. L., Zhu, X., Moreira, P. I., & Smith, M. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100669 · Cited by 61
The Many Faces of Glutathione Transferase Pi
Vasieva, O. (2011) · Current Molecular Medicine · doi:10.2174/156652411794859278 · Cited by 63
Trivedi, R. K., Polhemus, D. J., Li, Z., Yoo, D., Koiwaya, H., Scarborough, A. L., Goodchild, T. T., & Lefer, D. J. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008268 · Cited by 61
“However, we did observe an increase in PKG. 53 It is also important to consider that NPs also increase cGMP through their interaction with the NPR1 and NPR2 receptors.”
Self-citationThe Role of Mitochondrial Functional Proteins in ROS Production in Ischemic Heart Diseases
Pei, H., Yang, Y., Zhao, H., Li, X., Yang, D., Li, D., & Yang, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5470457 · Cited by 59
“Consistently, nitrite can modulate mitochondrial resilience to reperfusion injury, perhaps via inhibiting complex I by posttranslational s-nitrosation to reduce ROS generation [24, 25].”
BackgroundMaia, L. B., & Moura, J. J. G. (2018) · Redox Biology · doi:10.1016/j.redox.2018.08.020 · Cited by 54
Perlman, D. H., Bauer, S. M., Ashrafian, H., Bryan, N. S., Garcia-Saura, M. F., Lim, C. C., Fernandez, B. O., Infusini, G., McComb, M. E., Costello, C. E., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.187005 · Cited by 55
Preventing mitochondrial reverse electron transport as a strategy for cardioprotection
Prag, H. A., Murphy, M. P., & Krieg, T. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01002-4 · Cited by 61
“Similar mechanisms of cysteine modification and RET prevention may be part of the mechanism of protection from several agents that have been previously shown to be cardioprotective including hydrogen sulphide [50], hydrogen peroxide [57], sodium nitrite [148] and other S-nitrosothiols (Fig.”
BackgroundPolhemus, D. J., Gao, J., Scarborough, A. L., Trivedi, R. K., McDonough, K. H., Goodchild, T. T., Smart, F. W., Kapusta, D. R., & Lefer, D. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.308278 · Cited by 55
Self-citationCardioprotective PKG-independent NO signaling at reperfusion
Cohen, M. V., Yang, X., Liu, Y., Solenkova, N. V., & Downey, J. M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00527.2010 · Cited by 54
Bundgaard, A., James, A. M., Joyce, W., Murphy, M. P., & Fago, A. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.174391 · Cited by 56
“S-nitrosation of a specific Cys residue on the ND3 subunit of complex I can inhibit ROS generation during RET in mouse heart mitochondria (Chouchani et al., 2013) and protect the heart at re-oxygenation (Lesnefsky et al., 2004; Shiva et al., 2007).”
BackgroundInfluentialType 2 diabetes, mitochondrial biology and the heart
Sack, M. N. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.001 · Cited by 56
“The complex interplay between the molecular and biochemical mediators is epitomized by nitric oxide which not only upregulates mitochondrial biogenesis [30], but concurrently modulates oxidative phosphorylation through competitive inhibition of respiratory chain electron transfer [31,32].”
BackgroundSelf-citationNoda, K., Tanaka, Y., Shigemura, N., Kawamura, T., Wang, Y., Masutani, K., Sun, X., Toyoda, Y., Bermudez, C. A., & Nakao, A. (2012) · Transplant International · doi:10.1111/j.1432-2277.2012.01542.x · Cited by 52
“Complex I activity was determined spectrophotometrically (340 nm) by monitoring the oxidation of 100 lm NADH in the presence of 10 lm coenzyme Q2 and in the presence and absence of 25 lm rotenone [21].”
MethodForecasting elasmobranch survival following exposure to severe stressors
Renshaw, G. M. C., Kutek, A. K., Grant, G. D., & Anoopkumar‐Dukie, S. (2011) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2011.08.001 · Cited by 60
Nitrite therapy is neuroprotective and safe in cardiac arrest survivors
Dezfulian, C., Alekseyenko, A., Dave, K. R., Raval, A. P., Do, R., Kim, F., & Perez-Pinzon, M. A. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.007 · Cited by 52
“In other tissue types, including heart after cardiac arrest, nitrite therapy has been associated with a transient mitochondrial complex I inhibition with reduced free radical production at reperfusion and improved long term mitochondrial function and oxidant injury [21,51].”
Background
Metadata
- Authors
- Shiva, S., Sack, M. N., Greer, J. J., Duranski, M., Ringwood, L. A., Burwell, L., Wang, X., MacArthur, P. H., Shoja, A., Raghavachari, N., Calvert, J. W., Brookes, P. S., Lefer, D. J., & Gladwin, M. T.
- Affiliations
- 1Vascular Medicine Branch
- National Heart, Lung, and Blood Institute (US)
- Albert Einstein College of Medicine (US)
- University of Rochester Medicine (US)
- National Institutes of Health (US)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-08-06
- Volume
- 204
- Issue
- 9
- Pages
- 2089-2102
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118713
- OpenAlex
- W2116603854
- Cited by
- 555
- References
- 64
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 18 · 2023: 14 · 2022: 14 · 2021: 18 · 2020: 17 · 2019: 22 · 2018: 31 · 2017: 31 · 2016: 42 · 2015: 41 · 2014: 43 · 2013: 36 · 2012: 48
- FWCI
- 25.79
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL060849, R01-HL-60849)
- National Institute of Diabetes and Digestive and Kidney Diseases (F32DK077380)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- nitrite, ischemia-reperfusion injury, mitochondrial electron transport chain, S-nitrosylation, complex I, oxidative phosphorylation, mitochondrial permeability transition pore, cytochrome c release, reactive oxygen species, ischemic preconditioning, cardioprotection, hepatoprotection, aconitase, Mediterranean diet, nitric oxide
- MeSH terms
- Mitochondrial Permeability Transition Pore, Aconitate Hydratase, Administration, Oral, Animals, Electron Transport, Enzyme Activation, Liver, Male, Mice, Inbred C57BL, Mitochondria, Nitrites, Reperfusion Injury, Myocardial Reperfusion Injury, Ion Channel Gating, Rats, Sprague-Dawley, Reactive Oxygen Species, Molecular Mimicry, Ischemic Preconditioning, Cytoprotection, Mitochondrial Membrane Transport Proteins, Electron Transport Complex I, Cytochromes c, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.